Cerebral vascular dysfunction with aging

Handbook of the Biology of Aging

Volumn , Issue , 2011, Pages 405-419

  Faraci, Frank M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861110058     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-378638-8.00019-1     Document Type: Chapter

References (155)

1. Abbott N.J., Patabendige A.A.K., Dolman D.E.M., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiology of Disease 2010, 37:13-25.
2. 5 receptor subtype. Journal of Cerebral Blood Flow and Metabolism 2000, 20:298-305.
3. Andresen J.J., ShafiN.I., Bryan R.M. Endothelial influences on cerebrovascular tone. Journal of Applied Physiology 2006, 100(318-327):2006.
4. Arai K., Lo E.H. An oligovascular niche: Cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells. Journal of Neuroscience 2009, 29:4351-4355.
5. Argmann C., Dobrin R., Heikkinen S., Auburtin A., Pouilly L., Cock T.-A., et al. Pparγ2 is a key driver of longevity in the mouse. PLoS Genetics 2009, 5:e1000752.
6. Arribas S.M., Vila E., McGrath J.C. Impairment of vasodilator function in basilar arteries from aged rats. Stroke 1997, 28:1812-1820.
7. Basso N., Cini R., Pietrelli A., Ferder L., Terragno N.A., Inserra F. Protective effect of long-term angiotensin II inhibition. American Journal of Physiology 2007, 293:H1351-H1358.
8. Baumbach G.L., Sigmund C.D., Didion S.P., Faraci F.M. Hypertrophy of cerebral arterioles in mice deficient in expression of the gene for CuZn superoxide dismutase. Stroke 2006, 37:1850-1855.
9. Baumbach G.L., Sigmund C.D., Faraci F.M. Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen. Hypertension 2003, 41:50-55.
10. Baumbach G.L., Sigmund C.D., Faraci F.M. Structure of cerebral arterioles in mice deficient in expression of the gene for endothelial nitric oxide synthase. Circulation Research 2004, 95:822-829.
11. Benigni A., Corna D., Zoja C., Sonzogi A., Latini R., Salio M., et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. Journal of Clinical Investigation 2009, 119:524-530.
12. Berger J., Moller D.E. The mechanisms of action of PPARs. Annual Review of Medicine 2002, 53:409-435.
13. Bertsch K., Hagemann D., Hermes M., Walter C., Khan R., Naumann E. Resting cerebral blood flow, attention and aging. Brain Research 2009, 1267:77-88.
14. Beyer A.M., Baumbach G.L., Halabi C.M., Modrick M.L., Lynch C.M., Gerhold T.D., et al. Interference with PPARγ signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling. Hypertension 2008, 51:867-871.
15. Brandes R.P., Fleming I., Busse R. Endothelial aging. Cardiovascular Research 2005, 66:286-294.
16. Brian J.E. Carbon dioxide and the cerebral circulation. Anesthesiology 1998, 88:1365-1386.
17. Brown K.A., Chu Y., Lund D.D., Heistad D.D., Faraci F.M. Gene transfer of extracellular superoxide dismutase protects against vascular dysfunction with aging. American Journal of Physiology 2006, 290:H2600-H2605.
18. Brown K.A., Didion S.P., Andresen J.J., Faraci F.M. Effect of aging, MnSOD deficiency, and genetic background on endothelial function: Evidence for MnSOD haploinsufficiency. Arteriosclerosis, Thrombosis, and Vascular Biology 2007, 27:1941-1946.
19. Buchan K.W., Hassall D.G. PPAR agonists as direct modulators of the vessel wall in cardiovascular disease. Medicinal Research Reviews 2000, 20:350-366.
20. Bullitt E., Zeng D., Mortamet B., Ghosh A., Aylward S.R., Lin W., et al. The effects of healthy aging on intracerebral blood vessels visualized by magnetic resonance angiography. Neurobiology of Aging 2009, 31:290-300.
21. Burek M., Arias-Loza P.A., Roewer N., Forster C.Y. Claudin-5 as a novel estrogen target in vascular endothelium. Atherosclerosis, Thrombosis, and Vascular Biology 2010, 30:298-304.
22. Butt A.M., Jones H.C., Abbott N.J. Electrical resistance across the blood-brain barrier in anesthetized rats: A developmental study. Journal of Physiology 1990, 429:47-62.
23. Caligiuri G., Rudling M., Ollivier V., Jacob M.-P., Michel J.-B., Hansson G.K., et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Molecular Medicine 2003, 9:10-17.
24. Cassis P., Conti S., Remuzzi G., Benigni A. Angiotensin receptors as determinants of life span. Pflugers Archives 2010, 459:325-332.
25. Chen J., Zacharek A., Zhang C., Jiang H., Li Y., Roberts C., et al. Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. Journal of Neuroscience 2005, 25:2366-2375.
26. Chrissobolis S., Faraci F.M. The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends in Molecular Medicine 2008, 14:495-502.
27. Chrissobolis S., Faraci F.M. Sex differences in protection against angiotensin II-induced endothelial dysfunction by manganese superoxide dismutase in the cerebral circulation. Hypertension 2010, 55:905-991.
28. Chrissobolis S., Didion S.P., Kinzenbaw D.A., Schrader L.I., Dayal S., Lentz S.R., et al. Glutathione peroxidase plays a major role in protecting against angiotensin II-induced vascular dysfunction. Hypertension 2008, 51:872-877.
29. Cipolla M.J. The cerebral circulation. Integrated systems physiology: From molecule to function 2010, Morgan & Claypool Life Sciences, (in press). D.N. Granger, J. Granger (Eds.).
30. Cipolla M.J., Bullinger L.V. Reactivity of brain parenchymal arterioles after ischemia and reperfusion. Microcirculation 2008, 15:495-501.
31. Cipolla M.J., Bishop N., Vinke R.S., Godfrey J.A. PPARγ activation prevents hypertensive remodeling of cerebral arteries and improves vascular function in female rats. Stroke 2010, 14:1266-1270.
32. Cipolla M.J., Smith J., Kohlmeyer M.M., Godfrey J.A. SKCa and IKCa channels, myogenic tone, and vasodilator responses in middle cerebral arteries and parenchymal arterioles: Effect of ischemia and reperfusion. Stroke 2009, 40:1451-1457.
33. Cipolla M.J., Vitullo L., McKinnon J. Cerebral artery reactivity changes during pregnancy and the postpartum period: A role in eclampsia. American Journal of Physiology 2004, 286:H2127-H2132.
34. Csiszar A., Ungvari Z., Koller A., Edwards J.G., Kaley G. Inflammation and endothelial dysfunction during aging: Role of NF-κB. Journal of Applied Physiology 2008, 105:1333-1341.
35. D'Armiento F.P., Bianchi A., de Nigris F., Capuzzi D.M., D'Armiento M.R., Crimi G., et al. Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke 2001, 32:2472-2479.
36. De Caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A., et al. Nitric oxide decreases cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. Journal of Clinical Investigation 1995, 96:60-68.
37. Didion S.P., Heistad D.D., Faraci F.M. Mechanisms that produce nitric oxide-mediated relaxation of cerebral arteries during atherosclerosis. Stroke 2001, 32:761-766.
38. Didion S.P., Kinzenbaw D.A., Faraci F.M. Genetically-altered mice reveal a critical role for CuZnSOD in preventing angiotensin-II-induced endothelial dysfunction. Hypertension 2005, 46:1147-1153.
39. Didion S.P., Kinzenbaw D.A., Modrick M.L., Faraci F.M. Interleukin-10 protects against vascular dysfunction with aging [abstract]. FASEB Journal 2009, 23:805.15.
40. Didion S.P., Kinzenbaw D.A., Schrader L.I., Faraci F.M. Heterozygous CuZn superoxide dismutase deficiency produces a vascular phenotype with aging. Hypertension 2006, 48:1072-1079.
41. Didion S.P., Ryan M.J., Didion L.A., Fegan P.E., Sigmund C.D., Faraci F.M. Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circulation Research 2002, 91:938-944.
42. Donato A.J., Black A.D., Eskurza I., Silver A.E., Levy A.S., Pierce G.L., et al. Direct evidence of endothelial oxidative stress with aging in humans: Relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-κB. Circulation Research 2007, 100:1659-1666.
43. Donato A.J., Black A.D., Jablonski K.L., Gano L.B., Seals D.R. Aging is associated with greater NFκB, reduced IκBα, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans. Aging Cell 2008, 7:805-812.
44. Dupuis F., Regrigny O., Atkinson J., Liminana P., Delagrange P., Scalbert E., et al. Impact of treatment with melatonin on cerebral circulation in old rats. British Journal of Pharmacology 2004, 141:399-406.
45. Durrant J.R., Seals D.R., Connell M.L., Russell M.J., Lawson B.R., Folian B.J., et al. Voluntary wheel running restores endothelial function in conduit arteries of old mice: Direct evidence for reduced oxidative stress, increased superoxide dismutase activity and down-regulation of NADPH oxidase. Journal of Physiology 2009, 587:3271-3285.
46. Esposito L., Raber J., Kekonius L., Yan F., Yu G.-Q., Bien-Ly N., et al. Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. Journal of Neuroscience 2006, 26:5167-5179.
47. Faraci F.M. Cerebral circulation during aging. The regulation of cerebral blood flow 1993, 341-352. CRC Press, Boca Raton. J.W. Phillis (Ed.).
48. Faraci F.M. Role of endothelium in regulation of the brain microcirculation. Cerebral blood flow: Mechanisms of ischemia, diagnosis and therapy 2002, 17-25. Springer-Verlag, Berlin. M.R. Pinsky (Ed.).
49. Faraci F.M. Oxidative stress: The curse that underlies cerebral vascular dysfunction?. Stroke 2005, 36:186-188.
50. Faraci F.M. Hydrogen peroxide-watery fuel for change in vascular biology. Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26:1931-1933.
51. Faraci F.M. Protecting the brain with eNOS: Run for your life. Circulation Research 2006, 99:1029-1030.
52. Faraci F.M. Reactive oxygen species: Influence on cerebral vascular tone. Journal of Applied Physiology 2006, 100:739-743.
53. Faraci F.M. Surviving the remodel: The impact of hypertension during pregnancy. Hypertension 2008, 51:995-996.
54. Faraci F.M., Didion S.P. Vascular protection: Superoxide dismutase isoforms in the vessel wall. Arteriosclerosis, Thrombosis, and Vascular Biology 2004, 24:1367-1373.
55. Faraci F.M., Heistad D.D. Regulation of large cerebral arteries and cerebral microvascular pressure. Circulation Research 1990, 66:8-17.
56. Faraci F.M., Heistad D.D. Regulation of the cerebral circulation: Role of endothelium and potassium channels. Physiological Reviews 1998, 78:53-97.
57. Faraci F.M., Lamping K.G., Modrick M.L., Ryan M.J., Sigmund C.D., Didion S.P. Cerebral vascular effects of angiotensin II: New insights from genetic models. Journal of Cerebral Blood Flow and Metabolism 2006, 26:449-455.
58. Faraci F.M., Sigmund C.D., Shesely E.G., Maeda N., Heistad D.D. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. American Journal of Physiology 1998, 274:H564-H570.
59. Farkas E., Luiten P.G.M. Cerebral microvascular pathology in aging and Alzheimer's disease. Progress in Neurobiology 2001, 64:575-611.
60. Farrall A.J., Wardlaw J.M. Blood-brain barrier: Ageing and microvascular disease-systematic review and meta-analysis. Neurobiology of Aging 2009, 30:337-352.
61. Feletou M., Vanhoutte P.M. EDHF: An update. Clinical Science 2009, 117:139-155.
62. Finkel T. Radical medicine: Treating ageing to cure disease. Nature Reviews Molecular Cell Biology 2005, 6:971-976.
63. Folkow B., Svanborg A. Physiology of cardiovascular aging. Physiological Reviews 1993, 73:725-764.
64. Fujii K., Heistad D.D., Faraci F.M. Flow-mediated dilatation of the basilar artery in vivo. Circulation Research 1991, 69:697-705.
65. Garthwaite G., Bartus K., Malcolm D., Goodwin D., Kollb-Sielecka M., Dooldeniya C., et al. Signaling from blood vessels to CNS axons through nitric oxide. Journal of Neuroscience 2006, 26:7730-7740.
66. 2+]i. Journal of Applied Physiology 2003, 95:1746-1754.
67. Geddawy A., Shimosato T., Tawa M., Imamura T., Okamura T. Comparison of endothelium-related responses to nucleotides of dog and monkey cerebral arteries. Journal of Pharmacological Sciences 2010, 112:378-438.
68. Gertz K., Priller J., Kronenberg G., Fink K.B., Winter B., Schroeck H., et al. Physical activity improves long-term stroke outcome via eNOS-dependent augmentation of neo-vascularization and cerebral blood flow. Circulation Research 2006, 99:1132-1140.
69. Girouard H., Park L., Anrather J., Zhou P., Iadecola C. Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through Nox-2-derived radicals. Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26:826-832.
70. Girouard H., Park L., Anrather J., Zhou P., Iadecola C. Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II. Arteriosclerosis, Thrombosis, and Vascular Biology 2007, 27:303-309.
71. Gorelick P.B. Risk factors for vascular dementia and Alzheimer's disease. Stroke 2004, 35(Suppl. 1):2620-2622.
72. Gudiene D., Valancuite A., Velavicius J. Collagen network changes in basilar artery in aging. Medicina 2007, 43:964-970.
73. Gunnett C.A., Berg D.J., Faraci F.M. Vascular effects of lipopolysaccharide are enhanced in interleukin-10-deficient mice. Stroke 1999, 30:2191-2196.
74. Gunnett C.A., Heistad D.D., Berg D.J., Faraci F.M. Interleukin-10 deficiency increases superoxide and endothelial dysfunction during inflammation. American Journal of Physiology 2000, 279:H1555-H1562.
75. Gunnett C.A., Heistad D.D., Faraci F.M. Interleukin-10 protects endothelium-dependent relaxation during diabetes: Role of superoxide. Diabetes 2002, 51:1931-1937.
76. Hajdu M.A., Heistad D.D., Siems J.W., Baumbach G.L. Effects of aging on mechanics and composition of cerebral arterioles in rats. Circulation Research 1990, 66:1747-1754.
77. Hajdu M.A., McElmurry R.T., Heistad D.D., Baumbach G.L. Effects of aging on cerebral vascular responses to serotonin in rats. American Journal of Physiology 1993, 264:H2136-H2140.
78. Hatake K., Kakishita E., Wakabayashi I., Sakiyama N., Hishida S. Effect of aging on endothelium-dependent vascular relaxation of isolated human basilar artery to thrombin and bradykinin. Stroke 1990, 21:1039-1043.
79. Hatake K., Wakabayashi I., Kakishita E., Hishida S. Effect of aging on contractile response to KCl, norepinephrine, and 5-hydroxytryptamine in isolated human basilar artery. General Pharmacology 1992, 23:417-420.
80. Herrera M.D., Mingorance C., Rodriguez-Rodriguez R., Alvarez de Sotomayor M. Endothelial dysfunction and aging: An update. Ageing Research Reviews 2010, in press.
81. Hossmann K.A. Variability thresholds and the penumbra of focal ischemia. Annals of Neurology 1994, 36:557-565.
82. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nature Reviews Neuroscience 2004, 5:347-360.
83. Iadecola C. Threats to the mind: Aging, amyloid and hypertension. Stroke 2009, 40(Suppl. 1):S40-S44.
84. Iadecola C., Nedergaard M. Glia regulation of the cerebral microvasculature. Nature Neuroscience 2007, 10:1369-1376.
85. 2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism 2001, 50:3-11.
86. Ito H., Kanno I., Ibaraki M., Hatazawa J. Effect of aging on cerebral vascular responses to PaCO2 changes in humans as measured by positron emission tomography. Journal of Cerebral Blood Flow and Metabolism 2002, 22:997-1003.
87. Jacob A., Hack B., Chiang E., Garcia J.G.N., Quigg R.J., Alexander J.J. C5a alters blood-brain barrier integrity in experimental lupus. FASEB Journal 2010, 24:1682-1688.
88. Jagtop P., Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nature Reviews Drug Discovery 2005, 4:421-440.
89. Joutel A., Monet-Lepretre M., Gosele C., Baron-Menguy C., Hammes A., Schmidt S., et al. Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. Journal of Clinical Investigation 2010, 120:433-445.
90. Kaul S., Waack B.J., Padgett R.C., Brooks R.M., Heistad D.D. Altered vascular response to platelets from hypercholesterolemic humans. Circulation Research 1993, 72:737-743.
91. Kazama K., Anrather J., Zhou P., Girouard H., Frys K., Milner T.A., et al. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circulation Research 2004, 95:1019-1026.
92. Ketsawatsomkron P., Pelham C.J., Groh S., Keen H.L., Faraci F.M., Sigmund C.D. Does peroxisome proliferator-activated receptor γ (PPARγ) protect from hypertension directly through effects in the vasculature?. Journal of Biological Chemistry 2010, 285:9311-9316.
93. Koehler R.C., Roman R.J., Harder D.R. Astrocytes and the regulation of cerebral blood flow. Trends in Neuroscience 2009, 32:160-169.
94. Kuro-o M. Klotho as a regulator of oxidative stress and senescence. Biological Chemistry 2008, 389:233-241.
95. Lartaud I., Bray-des-Boscs L., Chillon J.M., Atkinson J., Capdeville-Atkinson C. In vivo cerebrovascular reactivity in Wistar and Fisher 344 rat strains during aging. American Journal of Physiology 1993, 264:H851-H858.
96. Lee M.Y., Griendling K.K. Redox signaling, vascular function, and hypertension. Antioxidants & Redox Signaling 2008, 10:1045-1059.
97. Lenaz G., Baracca A., Fato R., Genova M.L., Solaini G. New insights into structure and function of mitochondria and their role in aging and disease. Antioxidants & Redox Signaling 2006, 8:417-437.
98. Leopold J.A., Loscalzo J. Oxidative risk for atherothrombotic cardiovascular disease. Free Radical Biology & Medicine 2009, 47:1673-1706.
99. Lund D.D., Chu Y., Miller J.D., Heistad D.D. Protective effect of extracellular superoxide dismutase on endothelial function during aging. American Journal of Physiology 2009, 296:H1920-H1925.
100. Lyle A.N., Griendling K.K. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology 2006, 21:269-280.
101. Mallat Z., Besnard S., Duriez M., Deleuze V., Emmanuel F., Bureau M.F., et al. Protective role of interleukin-10 in atherosclerosis. Circulation Research 1999, 85:e17-e24.
102. Maneen M.J., Hannah R., Vitullo L., DeLance N., Cipolla M.J. Peroxynitrite diminishes myogenic activity and is associated with decreased vascular smooth muscle F-actin in rat posterior cerebral arteries. Stroke 2006, 37:894-899.
103. Marin J. Age-related changes in vascular responses: A review. Mechanisms of Ageing and Development 1995, 79:71-114.
104. Mayhan W.G., Heistad D.D. Permeability of blood-brain barrier to various sized molecules. American Journal of Physiology 1985, 248:H712-718.
105. Mayhan W.G., Arrick D.M., Sharpe G.M., Sun H. Age-related alterations in reactivity of cerebral arterioles: Role of oxidative stress. Microcirculation 2008, 15:225-236.
106. Mayhan W.G., Faraci F.M., Baumbach G.L., Heistad D.D. Effects of aging on response of cerebral arterioles. American Journal of Physiology 1990, 258:H1138-H1143.
107. Mehta P.K., Griendling K.K. Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system. American Journal of Physiology 2007, 292:C82-C97.
108. Miller A.A., Drummond G.R., Schmidt H.H.H.W., Sobey C.G. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circulation Research 2005, 97:1055-1062.
109. Modrick M.L., Didion S.P., Lynch C.M., Dayal S., Lentz S.R., Faraci F.M. Role of hydrogen peroxide and the impact of glutathione peroxidase-1 in regulation of cerebral vascular tone. Journal of Cerebral Blood Flow and Metabolism 2009, 29:1130-1137.
110. Modrick M.L., Didion S.P., Sigmund C.D., Faraci F.M. Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging. American Journal of Physiology 2009, 296:H1914-H1919.
111. Modrick M.L., Kinzenbaw D.A., Sigmund C.D., Faraci F.M. PPARγ protects against vascular dysfunction with aging [abstract]. Stroke 2010, 41:e32.
112. Muller-Delp J.M. Aging-induced adaptations of microvascular reactivity. Microcirculation 2006, 13:339-352.
113. Murphy S., Rich G., Orgren K.I., Moore S.A., Faraci F.M. Astrocyte-derived lipoxygenase product evokes endothelium-dependent relaxation of the basilar artery. Journal of Neuroscience Research 1994, 38:314-318.
114. Nagasawa S., Handa H., Okamura A., Naruo Y., Moritake K., Hayashi K. Mechanical properties of human cerebral arteries. I. Effects of age and vascular smooth muscle activation. Surgical Neurology 1979, 12:297-304.
115. Ngai A.C., Winn H.R. Modulation of cerebral arteriolar diameter by intraluminal flow and pressure. Circulation Research 1995, 77:832-840.
116. Nicolakakis N., Aboulkassim T., Ongali B., Lecrux C., Fernandes P., Rosa-Neto P., et al. Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist. Journal of Neuroscience 2008, 28:9287-9296.
117. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. Journal of Cell Biology 2003, 161:653-660.
118. Ogawa K., Tokinaga Y., Iwahashi S., Mizumoto K., Hatano Y. Halothane does not protect against vascular injury in isolated cerebral and mesenteric arteries. Canadian Journal of Anesthesiology 2005, 52:870-877.
119. Park L., Anrather J., Girouard H., Zhou P., Iadecola C. Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain. Journal of Cerebral Blood Flow and Metabolism 2007, 27:1908-1918.
120. Park L., Zhou P., Pitstick R., Capone C., Anrather J., Norris E.H., et al. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:1347-1352.
121. Paterno R., Faraci F.M., Heistad D.D. Age-related changes in release of endothelium-derived relaxing factor from the carotid artery. Stroke 1994, 25:2457-2460.
122. Popescu B.O., Toescu E.C., Popescu L.M., Bajenaru O., Muresanu D.F., Schultzberg M., et al. Blood-brain barrier alterations in ageing and dementia. Journal of the Neurological Sciences 2009, 283:99-106.
123. Pun P.M.L., Lu J., Moochhala S. Involvement of ROS in BBB dysfunction. Free Radical Research 2009, 43:348-364.
124. Rakugi H., Matsukawa N., Ishikawa K., Yang J., Imai M., Ikushima M., et al. Anti-oxidant effect of klotho on endothelial cells through cAMP activation. Endocrine 2007, 31:82-87.
125. Rippe C., Lesniewski L., Connell M., LaRocca T., Donata A., Seals D. Short-term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress. Aging Cell 2010, 9:304-312.
126. Rodriguez-Manas L., El-Assar M., Vallejo S., Lopez-Doriga P., Solis J., Petidier R., et al. Endothelial dysfunction in aged humans is related to oxidative stress and vascular inflammation. Aging Cell 2009, 8:226-238.
127. Rothwell P.M., Coull A.J., Silver L.E., Fairhead J.F., Giles M.F., Lovelock C.E., et al. Oxford Vascular Study: Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories. Lancet 2005, 366:1773-1783.
128. Santos R.A.S., Ferreira A.J., Simoes e Silva A.C. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Experimental Physiology 2008, 93:519-527.
129. Savoia C., Schiffrin E.L. Vascular inflammation in hypertension and diabetes: Molecular mechanisms and therapeutic interventions. Clinical Science 2007, 112:375-384.
130. Scalera F., Martens-Lobenhoffer J., Bukowska A., Lendeckel U., Tager M., Bode-Boger S.M. Effect of telmisartan on nitric oxide-asymmetrical dimethylarginine system: Role of angiotensin II type 1 receptor and peroxisome proliferator activated receptor γ signaling during endothelial aging. Hypertension 2008, 51:696-703.
131. Schiffrin E.L. Peroxisome proliferator-activated receptors and cardiovascular remodeling. American Journal of Physiology 2005, 288:H1037-H1043.
132. Schrader L.I., Kinzenbaw D.A., Johnson A.W., Faraci F.M., Didion S.P. IL-6 deficiency protects against angiotensin II-induced endothelial dysfunction and hypertrophy. Arteriosclerosis, Thrombosis, and Vascular Biology 2007, 27:2576-2581.
133. Schreibelt G., Kooij G., Reijerkerk A., Van Doorn R., Gringhuis S.I., Van der Pol S., et al. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB Journal 2007, 21:3666-3676.
134. Shen Q., Goderie S.K., Jin L., Karanth N., Sun Y., Abramova N., et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 2004, 304:1338-1340.
135. Shin H.K., Jones P.B., Garcia-Alloza M., Borrelli L., Greenberg S.M., Bacskai B.J., et al. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain 2007, 130:2310-2319.
136. Sobey C.G., Faraci F.M. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. Stroke 1997, 28:837-843.
137. + channels. Stroke 1997, 28:2290-2294.
138. Sonntag W.E., Eckman D.M., Ingraham J., Riddle D.R. Regulation of cerebrovascular aging. Brain aging: Models, methods and mechanisms 2007, 279-304. CRC Press, Boca Raton. D.R. Riddle (Ed.).
139. Stoquart-El Sankari S., Baledent O., Gondry-Jouet C., Makki M., Godefroy O., Meyer M.-E. Aging effects on cerebral blood and cerebrospinal fluid flows. Journal of Cerebral Blood Flow and Metabolism 2007, 27:1563-1572.
140. Sugawara A., Takeuchi K., Uruno A., Ikeda Y., Arima S., Kudo M., et al. Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells. Endocrinology 2001, 142:3125-3134.
141. Sung B., Park S., Yu B.P., Chung H.Y. Modulation of PPAR in aging, inflammation, and calorie restriction. Journals of Gerontology, Series A, Biological Sciences and Medical Sciences 2004, 59:997-1006.
142. Toyoda K., Fujii K., Takata S., Ibayashi S., Kitazono T., Nagao T., et al. Age-related changes in response of brain stem vessels to opening of ATP-sensitive potassium channels. Stroke 1997, 28:171-175.
143. Tsukada H., Sato K., Kakiuchi T., Nishiyama S. Age-related impairment of coupling mechanism between neuronal activation and functional cerebral blood flow response was restored by cholinesterase inhibition: PET study with microdialysis in the awake monkey brain. Brain Research 2000, 857:158-164.
144. Vaishnav R.A., Getchell M.L., Poon H.F., Barnett K.R., Hunter S.A., Pierce W.M, et al. Oxidative stress in the aging murine olfactory bulb: Redox proteomics and cellular localization. Journal of Neuroscience Research 2007, 85:373-385.
145. Van der Loo B., Labugger R., Skepper J.N., Bachschmid M., Kilo J., Powell J.M., et al. Enhanced peroxynitrite formation is associated with vascular aging. Journal of Experimental Medicine 2000, 192:1731-1744.
146. Vorbrodt A.W., Dobrogowska D.H., Meeker H.C., Carp R.I. Immunogold study of regional differences in the distribution of glucose transporter (GLUT-1) in mouse brain associated with physiological and accelerated aging and scrapie infection. Journal of Neurocytology 1999, 28:711-719.
147. Wang M., Takagi G., Asai K., Resuello R.G., Natividad F.F., Vatner D.E., et al. Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension 2003, 41:1308-1316.
148. Wang M., Zhang J., Jiang L.-Q., Spinetti G., Pintus G., Monticone R., et al. Proinflammatory profile within the grossly normal aged human aortic wall. Hypertension 2007, 50:219-227.
149. Weller R.O., Boche D., Nicoll J.A.R. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathologica 2009, 118:87-102.
150. Xudong X., Junzhu C., Xingziang W., Furong Z., Yanrong L. Age- and gender-related difference of ACE2 expression in rat lung. Life Sciences 2006, 78:2166-2171.
151. Yang H.-C., Deleuze S., Zuo Y., PotthoffS.A., Ma L.-J., Fogo A.B. The PPARγ agonist pioglitazone ameliorates aging-related progressive renal injury. Journal of the American Society of Nephrology 2009, 20:2380-2388.
152. Zeiher A.M., Drexler H., Saurbier B., Just H. Endothelium-mediated coronary blood flow modulation in humans: Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. Journal of Clinical Investigation 1993, 92:652-662.
153. Zhang H., Li Y., Fan Y., Wu J., Zhao B., Guan Y., et al. Klotho is a target gene of PPARγ. Kidney International 2008, 74:732-739.
154. Zhang H., Park Y., Wu J., Chen X.P., Lee S., Yang J., et al. Role of TNF-α in vascular dysfunction. Clinical Science 2009, 116:219-230.
155. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.